Teva plans to close Montreal plant

Teva Pharmaceutical Industries will divest itself of a Montreal-based plant it inherited from its buyout of Ratiopharm last year. The plant, which employs 340 people, has already been put up for sale. But if no buyers emerge, layoffs will begin next March. Report

Suggested Articles

The FDA is bracing for drug and medical supply shortages in the U.S. as the COVID-19 outbreak from China continues to spread globally.

Astellas and Seattle Genetics are out with Padcev-Keytruda combo data that may be good enough to snag an expedited regulatory review, analysts say.

Distributors had offered billions of dollars to wrap up opioid litigation, but that effort has suffered a major setback, WSJ reports.